Can HALP score, a new prognostic tool, take the place of traditional scoring systems in Fournier's gangrene?

Yükleniyor...
Küçük Resim

Tarih

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Springer

Erişim Hakkı

info:eu-repo/semantics/embargoedAccess

Özet

Purpose Fournier’s Gangrene (FG) is a fatal condition, therefore prognosis prediction is a crucial step before treatment planning. We aimed to investigate the predictive value of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) score which is frequently employed in vascular disorders and malignancies, on disease severity and survival in FG patients and to compare HALP score with well-known scoring systems on this aspect. Materials and methods Eighty-seven men who had surgical debridement for FG between December 2006 and January 2022 were included in this study. Their symptoms, physical examination fndings, laboratory tests, medical histories, vital signs, extent and timing of the surgical debridement and antimicrobial therapies were noted. The HALP score, Age-adjusted Charlson Comorbidity Index (ACCI) and Fournier’s Gangrene Severity Index (FGSI) were evaluated for their predictive values for survival. Results FG patients were grouped as survivors (Group 1, n=71) and non-survivors (Group 2, n=16) and the results were compared. The mean ages of survivors (59±12.55 years) and non-survivors (64.5±14.6 years) were similar (p=0.114). The median size of necrotized body surface area was 3% in Group 1 and 4.8% in Group 2 (p=0.013). On admission, hemoglobin, albumin and serum urea levels and white blood cell counts were signifcantly diferent in two study groups. Two study groups were similar for HALP scores. However, ACCI and FGSI scores were greater signifcantly in non-survivors. Conclusions Our results indicated that HALP score does not predict a survival successfully in FG. However, FGSI and ACCI are successful outcome predictors in FG.

Açıklama

Şenel, Çağdaş (Balikesir Author)

Anahtar Kelimeler

Fournier’s Gangrene, HALP Score, FGSI, ACCI, Prognosis, Severity

Kaynak

International Urology and Nephrology

WoS Q Değeri

Scopus Q Değeri

Cilt

Early Access JUL 2023

Sayı

Künye

Onay

İnceleme

Ekleyen

Referans Veren